Skip to content
Home/Companies/HealthTech/Alex Therapeutics

Alex Therapeutics

HealthTech·Sweden·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Alex Therapeutics?

Alex Therapeutics is a Swedish HealthTech company, currently owned by Scale Capital since 2022.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Scale Capital
Investor
Scale Capital
Scale Capital Fund III · 2022 · VC

Key facts

HQSweden
SectorHealthTech
StatusActive

More from Scale Capital Fund III

Other portfolio companies in the same fund.

Blykalla
Active
ClimateTechSweden· 2026
Six Robotics
Active
Aerospace & DefenceNorway· 2026
All Gravy
All Gravy
Active
HR TechDenmark· 2025
ARX Robotics
Active
Aerospace & DefenceGermany· 2025
Bsure
Active
CybersecurityNorway· 2025
Sonair
Active
Deep TechNorway· 2025

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Alex Therapeutics?

Alex Therapeutics is currently owned by Scale Capital, through Scale Capital Fund III, since 2022.

When did Scale Capital acquire Alex Therapeutics?

Scale Capital acquired Alex Therapeutics in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue